Macrolide-Resistant Mycoplasma pneumoniae in Children, Ohio, USA.
As the COVID-19 pandemic waned, Mycoplasma pneumoniae reemerged in the pediatric population in Ohio, USA. The rate of macrolide-resistant M. pneumoniae fluctuated by month, ranging from 0 to 8.7%, and mirrored the azithromycin prescribing rate. Real-time surveillance for macrolide-resistant M. pneumoniae provides accurate information for management of children with these infections.
Authors
Wang Wang, Embry Embry, Everhart Everhart, Szekely Szekely, Taveras Taveras, Oyeniran Oyeniran, Leber Leber
View on Pubmed